Navigation Links
BioScrip To Host Third Quarter 2013 Earnings Call
Date:10/21/2013

ELMSFORD, N.Y., Oct. 21, 2013 /PRNewswire/ -- BioScrip®, Inc. (NASDAQ: BIOS) announced today that the Company will release its 2013 third quarter financial results on Wednesday, November 6, 2013, after the market closes.

(Logo: http://photos.prnewswire.com/prnh/20130117/NY44138LOGO )

The Company will host a conference call at 8:30 a.m. Eastern Standard Time (EST) on Thursday, November 7, 2013. Richard Smith, President and Chief Executive Officer, and Hai Tran, Chief Financial Officer, will conduct the call.

Interested parties may participate in the conference call by dialing 800-679-2940 (US), or 303-223-2689 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available for two weeks after the call's completion by dialing 800-633-8284 (US) or 402-977-9140 (International) and entering conference call ID number 21682095. An audio webcast and archive will also be available for 30 days under the "Investor Relations" section of the BioScrip website at www.bioscrip.com.

About BioScrip, Inc.

BioScrip, Inc. is a leading national provider of infusion and home care solutions.  BioScrip partners with physicians, healthcare payors, government agencies, hospital systems and pharmaceutical manufacturers to provide patients access to post-acute care services.  BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting.  By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by quality, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.  BioScrip provides its infusion and home care services from 108 locations across 29 states.


'/>"/>
SOURCE BioScrip, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioScrip Announces 2013 Investor Day
2. BioScrip Extends The Consent Payment Deadline And Expiration Date To July 30 For Its Previously Announced Tender Offer And Consent Solicitation
3. BioScrip Reports First Quarter 2013 Financial Results
4. BioScrip To Present At "NINE" Noble Financial Capital Markets Ninth Annual Equity Conference
5. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
6. Actavis, Inc. to Host Third Quarter 2013 Earnings Conference Call and Webcast
7. Synerons elure Brings Home Allure Magazines Best of Beauty Award, for the Third Consecutive Year
8. Zimmer Announces Quarterly Dividend for Third Quarter of 2013
9. PDL BioPharma Provides Third Quarter 2013 Revenue Guidance of $97 Million
10. MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results
11. PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):